Other Ingredients: Starch, Dibasic Calcium Phosphate, Polyvinyl Pyrrolidone (PVP), Crosscarmellose Sodium, Anti-caking Agent
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus (Mounjaro) and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities (Zepbound)
The body tightly regulates copper levels, and excess copper is normally excreted through bile
Novo Nordisk, the manufacturer of Ozempic and Wegovy, could not produce enough to meet demand
Clinical trials demonstrate significant reductions in hepatic steatosis with semaglutide and liraglutide, though fibrosis improvement remains modest